211 related articles for article (PubMed ID: 30779721)
1. MDR1 gene polymorphism correlated with pathological characteristics and prognosis in patients with primary hepatocellular carcinoma receiving interventional therapy.
Hu W; Huang S; Dong L; Yu C; Li C; Zhang J
Anticancer Drugs; 2019 Mar; 30(3):233-240. PubMed ID: 30779721
[TBL] [Abstract][Full Text] [Related]
2. Association of C3435T, C1236T and C4125A Polymorphisms of the MDR-1 Gene in Egyptian Children with Acute Lymphoblastic Leukaemia.
Talaat RM; Y K El-Kelliny M; El-Akhras BA; Bakry RM; Riad KF; Guirgis AA
Asian Pac J Cancer Prev; 2018 Sep; 19(9):2535-2543. PubMed ID: 30256048
[TBL] [Abstract][Full Text] [Related]
3. Genetic variants in the KDR gene is associated with the prognosis of transarterial chemoembolization treated hepatocellular carcinoma.
Zheng YB; Huang JW; Zhan MX; Zhao W; Liu B; He X; Li Y; Hu BS; Lu LG
Tumour Biol; 2014 Nov; 35(11):11473-81. PubMed ID: 25123269
[TBL] [Abstract][Full Text] [Related]
4. MDR1 polymorphisms have an impact on the prognosis of Chinese diffuse large B cell lymphoma patients.
Ni Y; Yin G; Xiao Z; Fan L; Wang L; Wu Y; Wu H; Qian S; Xu W; Li J; Miao K; Qiu H
Tumour Biol; 2016 Jan; 37(1):1237-44. PubMed ID: 26286835
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the C3435T polymorphism in the MDR1 gene in patients with hepatocellular carcinoma.
Baldissera VD; de Mattos AA; Coral GP; de Araujo FB; Marroni CA; de Mello Brandão AB; Ott Fontes PR; Schmidt Cerski CT; Hartmann AA; Kretzmann Filho NA
Ann Hepatol; 2012; 11(6):899-906. PubMed ID: 23109454
[TBL] [Abstract][Full Text] [Related]
6. Roles of XRCC1/XPD/ERCC1 Polymorphisms in Predicting Prognosis of Hepatocellular Carcinoma in Patients Receiving Transcatheter Arterial Chemoembolization.
Wang XC; Wang F; Quan QQ
Genet Test Mol Biomarkers; 2016 Apr; 20(4):176-84. PubMed ID: 26918371
[TBL] [Abstract][Full Text] [Related]
7. Correlations of IL-23R gene polymorphism with clinicopathological characteristics and prognosis of hepatocellular carcinoma patients after interventional therapy.
Pan X; Wang G
Genomics; 2019 Jul; 111(4):930-935. PubMed ID: 29864461
[TBL] [Abstract][Full Text] [Related]
8. LncRNA H19 modulated by miR-146b-3p/miR-1539-mediated allelic regulation in transarterial chemoembolization of hepatocellular carcinoma.
Song Y; Xing H; Zhou L; Zhang N; Yang M
Arch Toxicol; 2021 Sep; 95(9):3063-3070. PubMed ID: 34251499
[TBL] [Abstract][Full Text] [Related]
9. Genetic variants in the EPCAM gene is associated with the prognosis of transarterial chemoembolization treated hepatocellular carcinoma with portal vein tumor thrombus.
Yu X; Ge N; Guo X; Shen S; Liang J; Huang X; Wan S; Xing J; Huang Q; Yang Y
PLoS One; 2014; 9(4):e93416. PubMed ID: 24718422
[TBL] [Abstract][Full Text] [Related]
10. Genetic Variants in ASCT2 Gene are Associated with the Prognosis of Transarterial Chemoembolisation-Treated Early- Stage Hepatocelluar Carcinoma.
Ge NJ; Shi ZY; Yu XH; Huang XJ; Wu YS; Chen YY; Zhang J; Yang YF
Asian Pac J Cancer Prev; 2015; 16(9):4103-7. PubMed ID: 25987094
[TBL] [Abstract][Full Text] [Related]
11. Functional polymorphisms in the NPAS2 gene are associated with overall survival in transcatheter arterial chemoembolization-treated hepatocellular carcinoma patients.
Yuan P; Wang S; Zhou F; Wan S; Yang Y; Huang X; Zhang Z; Zhu Y; Zhang H; Xing J
Cancer Sci; 2014 Jul; 105(7):825-32. PubMed ID: 24754267
[TBL] [Abstract][Full Text] [Related]
12. [Relation between single Nucleotide Polymorphisms of CYP3A5 Gene and MDR1 Gene Loci and Risk of CML Cytogenetic Relapse].
Yang ZY; Zhang YS; Liang CX; Zhou ZJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Dec; 26(6):1644-1648. PubMed ID: 30501698
[TBL] [Abstract][Full Text] [Related]
13. Clinical efficacy of postoperative adjuvant transcatheter arterial chemoembolization on hepatocellular carcinoma.
Liu C; Sun L; Xu J; Zhao Y
World J Surg Oncol; 2016 Apr; 14():100. PubMed ID: 27038790
[TBL] [Abstract][Full Text] [Related]
14. FOXP3 gene polymorphism is associated with hepatitis B-related hepatocellular carcinoma in China.
Chen Y; Zhang H; Liao W; Zhou J; He G; Xie X; Fei R; Qin L; Wei L; Chen H
J Exp Clin Cancer Res; 2013 Jun; 32(1):39. PubMed ID: 23759077
[TBL] [Abstract][Full Text] [Related]
15. MiR-608 rs4919510 is associated with prognosis of hepatocellular carcinoma.
Ma XP; Yu G; Chen X; Xiao Q; Shi Z; Zhang LY; Chen H; Zhang P; Ding DL; Huang HX; Saiyin H; Chen TY; Lu PX; Wang NJ; Yu H; Conran C; Sun J; Zheng SL; Xu J; Yu L; Jiang DK
Tumour Biol; 2016 Jul; 37(7):9931-42. PubMed ID: 26815502
[TBL] [Abstract][Full Text] [Related]
16. A functional polymorphism in PER3 gene is associated with prognosis in hepatocellular carcinoma.
Zhao B; Lu J; Yin J; Liu H; Guo X; Yang Y; Ge N; Zhu Y; Zhang H; Xing J
Liver Int; 2012 Oct; 32(9):1451-9. PubMed ID: 22809120
[TBL] [Abstract][Full Text] [Related]
17. Association of PINX1 but not TEP1 Polymorphisms with Progression to Hepatocellular Carcinoma in Thai Patients with Chronic Hepatitis B Virus Infection.
Sriprapun M; Chuaypen N; Khlaiphuengsin A; Pinjaroen N; Payungporn S; Tangkijvanich P
Asian Pac J Cancer Prev; 2016; 17(4):2019-25. PubMed ID: 27221889
[TBL] [Abstract][Full Text] [Related]
18. Donor one‑carbon metabolism gene single nucleotide polymorphisms predict the susceptibility of cancer recurrence after liver transplantation.
Wang C; Lu D; Ling Q; Chen J; Liu Z; Guo H; Xu X; Zheng S
Gene; 2019 Mar; 689():97-101. PubMed ID: 30529095
[TBL] [Abstract][Full Text] [Related]
19. A Case-Control Study on the Correlation Between Thymidylate Synthase Gene Polymorphisms and Raltitrexed Treatment Combined with Transcatheter Arterial Chemoembolization in Hepatocellular Carcinoma Treatment.
Qi C; Gao H; Li S; Zong H; Hao H; Zhang L
Genet Test Mol Biomarkers; 2020 Mar; 24(3):156-164. PubMed ID: 32101052
[No Abstract] [Full Text] [Related]
20. Therapeutic value of transcatheter arterial chemoembolization combined with portal vein embolization for primary hepatocellular carcinoma with portal vein tumor thrombus: a pilot study.
Tan X; Xie P; Liu J; Wu H; Xie Y
Asia Pac J Clin Oncol; 2015 Sep; 11(3):e6-e12. PubMed ID: 25228074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]